Evgen Pharma (LON:EVG)

Evgen Pharma (LON:EVG)


Share Price
17.75 p
Change
0.125 (0.71 %)
Market Cap
£23.54 m
Proactive Investors - Run By Investors For Investors

Evgen Pharma

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

EPIC: EVG
Market: AIM:EVG
52-week High/Low: 33.000p / 13.250p
Sector: Pharma & Biotech
Market Cap: £23.54 m
Website: evgen.com
col 3
col 4
col 5
col 6

Evgen Pharma Timeline

RNS
10:00
RNS
Thu
RNS
June 13 2019
RNS
May 22 2019
RNS
May 10 2019
RNS
May 09 2019
Newswire
December 13 2018
Research Video
March 08 2018

Columns Including EVG

VIEW ALL

Market Reports Including EVG

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use